Stephen Shrewsbury
Directeur/Membre du Conseil chez BioXpertz LLC
Postes actifs de Stephen Shrewsbury
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioXpertz LLC | Directeur/Membre du Conseil | - | - |
Historique de carrière de Stephen Shrewsbury
Anciens postes connus de Stephen Shrewsbury
Sociétés | Poste | Début | Fin |
---|---|---|---|
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Directeur Technique/Scientifique/R&D | 01/06/2016 | 01/12/2016 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 03/04/2013 | 01/01/2016 |
SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2009 | 20/06/2011 |
Conseiller Juridique Général | 01/02/2009 | 20/06/2011 | |
ADAMAS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2008 | 01/08/2008 |
Conseiller Juridique Général | 01/08/2008 | 01/08/2008 | |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Directeur Technique/Scientifique/R&D | 01/03/2008 | 01/03/2008 |
Conseiller Juridique Général | 01/03/2008 | 01/03/2008 | |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/02/2005 | 01/02/2005 |
IPI LEGACY LIQUIDATION CO | Directeur Technique/Scientifique/R&D | 01/03/2017 | - |
GSK PLC | Directeur/Membre du Conseil | - | - |
Corporate Officer/Principal | - | - |
Formation de Stephen Shrewsbury
The University of Liverpool | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Royaume-Uni | 3 |
Canada | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 6 |
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 9 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
IPI LEGACY LIQUIDATION CO | Health Technology |
GSK PLC | Health Technology |
Entreprise privées | 6 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
BioXpertz LLC | |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Health Technology |
- Bourse
- Insiders
- Stephen Shrewsbury
- Expérience